Table 4. A2A and NR2B receptor antagonist combinations tested either alone or in combination as add-on therapy to L-Dopa in 6-OHDA-lesioned rats.
A2A receptor antagonist drugs | NR2B receptor antagonist drugs |
Sch-58261 0.3 mg/kg (ip) | Co-101244 1 mg/kg (ip) |
Preladenant 0.03 mg/kg (ip) | Radiprodil 0.3 mg/kg (ip) |
Preladenant 0.03 mg/kg (ip) | Merck 22 1 mg/kg (ip) |
Tozadenant 30 mg/kg (po) | Radiprodil 3 mg/kg (po) |